Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
Joséphine Muller(University of Liège), Jo Caers(University of Liège)
Cited by 20
Related Papers
Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
|British Journal of Cancer|2008|35